Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | NASUS PHARMA LTD | — | 359,390.0 | $1.3M | 0.77% | — | — | $3.50 | — |
| 22 | PROF | PROFOUND MED CORP | Healthcare | 170,278.0 | $1.1M | 0.69% | -115K | -40.4% | $6.65 | +3.0% |
| 23 | — | JASPER THERAPEUTICS INC | — | 2,668,395.0 | $1.1M | 0.68% | — | — | $0.42 | — |
| 24 | — CALL | TENAX THERAPEUTICS INC | — | 68,700.0 | $1000K | 0.61% | NEW | — | $14.55 | — |
| 25 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,700.0 | $454K | 0.28% | — | — | $122.58 | +17.7% |
| 26 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 120,000.0 | $450K | 0.27% | -420K | -77.8% | $3.75 | -14.4% |
| 27 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 230,000.0 | $391K | 0.24% | +150K | +187.5% | $1.70 | -18.2% |
| 28 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 16,000.0 | $388K | 0.24% | — | — | $24.26 | +8.0% |
| 29 | OVID | OVID THERAPEUTICS INC | Healthcare | 130,000.0 | $350K | 0.21% | -30K | -18.8% | $2.69 | +4.1% |
| 30 | — | PRECISION BIOSCIENCES INC | — | 40,000.0 | $314K | 0.19% | — | — | $7.86 | — |
| 31 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 11,000.0 | $297K | 0.18% | — | — | $26.98 | -5.1% |
| 32 | MGNX | MACROGENICS INC | Healthcare | 60,000.0 | $277K | 0.17% | +30K | +100.0% | $4.62 | -10.6% |
| 33 | — | CORBUS PHARMACEUTICALS HLDGS | — | 26,000.0 | $244K | 0.15% | — | — | $9.38 | — |
| 34 | — | ARTIVA BIOTHERAPEUTICS INC | — | 25,000.0 | $242K | 0.15% | — | — | $9.70 | — |
| 35 | REPL | REPLIMUNE GROUP INC | Healthcare | 20,000.0 | $221K | 0.14% | — | — | $11.07 | +40.0% |
| 36 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 10,000.0 | $219K | 0.13% | — | — | $21.86 | -10.6% |
| 37 | IMNM | IMMUNOME INC | Healthcare | 10,000.0 | $212K | 0.13% | — | — | $21.19 | +30.1% |
| 38 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 6,000.0 | $206K | 0.13% | NEW | — | $34.38 | +3.6% |
| 39 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 60,000.0 | $205K | 0.12% | -235K | -79.6% | $3.42 | +12.9% |
| 40 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 20,000.0 | $195K | 0.12% | +5K | +33.3% | $9.77 | -80.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%